Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Regulatory acceptability of the minipig in the development of pharmaceuticals, chemicals and other products.

van der Laan JW, Brightwell J, McAnulty P, Ratky J, Stark C; Steering Group of the RETHINK Project.

J Pharmacol Toxicol Methods. 2010 Nov-Dec;62(3):184-95. doi: 10.1016/j.vascn.2010.05.005. Epub 2010 Jun 16. Review.

PMID:
20601024
2.

The minipig as nonrodent species in toxicology--where are we now?

Ganderup NC, Harvey W, Mortensen JT, Harrouk W.

Int J Toxicol. 2012 Nov-Dec;31(6):507-28. doi: 10.1177/1091581812462039. Epub 2012 Nov 6.

PMID:
23134714
3.

The RETHINK project on minipigs in the toxicity testing of new medicines and chemicals: conclusions and recommendations.

Forster R, Bode G, Ellegaard L, van der Laan JW.

J Pharmacol Toxicol Methods. 2010 Nov-Dec;62(3):236-42. doi: 10.1016/j.vascn.2010.05.008. Epub 2010 May 31. Review.

PMID:
20685309
4.

The RETHINK project--minipigs as models for the toxicity testing of new medicines and chemicals: an impact assessment.

Forster R, Bode G, Ellegaard L, van der Laan JW; Steering Group of the RETHINK Project.

J Pharmacol Toxicol Methods. 2010 Nov-Dec;62(3):158-9. doi: 10.1016/j.vascn.2010.05.003. Epub 2010 Jun 1.

PMID:
20685395
5.

The utility of the minipig as an animal model in regulatory toxicology.

Bode G, Clausing P, Gervais F, Loegsted J, Luft J, Nogues V, Sims J; Steering Group of the RETHINK Project.

J Pharmacol Toxicol Methods. 2010 Nov-Dec;62(3):196-220. doi: 10.1016/j.vascn.2010.05.009. Epub 2010 May 31. Review.

PMID:
20685310
6.

Ethical implications of using the minipig in regulatory toxicology studies.

Webster J, Bollen P, Grimm H, Jennings M; Steering Group of the RETHINK Project.

J Pharmacol Toxicol Methods. 2010 Nov-Dec;62(3):160-6. doi: 10.1016/j.vascn.2010.05.002. Epub 2010 May 31.

PMID:
20566379
7.

Welfare of the minipig with special reference to use in regulatory toxicology studies.

Ellegaard L, Cunningham A, Edwards S, Grand N, Nevalainen T, Prescott M, Schuurman T; Steering Group of the RETHINK Project.

J Pharmacol Toxicol Methods. 2010 Nov-Dec;62(3):167-83. doi: 10.1016/j.vascn.2010.05.006. Epub 2010 May 31. Review.

PMID:
20621655
8.

The minipig in toxicology.

Svendsen O.

Exp Toxicol Pathol. 2006 Jul;57(5-6):335-9. Epub 2006 May 24.

PMID:
16725317
9.

Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.

EFSA GMO Panel Working Group on Animal Feeding Trials.

Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Review.

PMID:
18328408
10.

The RETHINK project: impact of toxicity testing in the minipig as an alternative approach in regulatory toxicity testing.

Curtis MJ.

J Pharmacol Toxicol Methods. 2010 Nov-Dec;62(3):157. doi: 10.1016/j.vascn.2010.08.001. Epub 2010 Aug 6. No abstract available.

PMID:
20692353
11.

Swine as models in biomedical research and toxicology testing.

Swindle MM, Makin A, Herron AJ, Clubb FJ Jr, Frazier KS.

Vet Pathol. 2012 Mar;49(2):344-56. doi: 10.1177/0300985811402846. Epub 2011 Mar 25. Review. Erratum in: Vet Pathol. 2012 Jul;49(4):738.

PMID:
21441112
13.

Comparison of minipig, dog, monkey and human drug metabolism and disposition.

Dalgaard L.

J Pharmacol Toxicol Methods. 2015 Jul-Aug;74:80-92. doi: 10.1016/j.vascn.2014.12.005. Epub 2014 Dec 27. Review.

PMID:
25545337
14.

US regulation of combination products.

Donawa M.

Med Device Technol. 2009 Oct;20(6):22, 24-5.

PMID:
20302139
15.

Combination products regulation at the FDA.

Lauritsen KJ, Nguyen T.

Clin Pharmacol Ther. 2009 May;85(5):468-70. doi: 10.1038/clpt.2009.28.

PMID:
19381151
16.

Pharmaceuticals and medical devices: medical devices.

Berry MD.

Issue Brief Health Policy Track Serv. 2013 Dec 30:1-49. No abstract available.

PMID:
24482892
17.

The minipig in dermatotoxicology: methods and challenges.

Mahl JA, Vogel BE, Court M, Kolopp M, Roman D, Nogu├ęs V.

Exp Toxicol Pathol. 2006 Jul;57(5-6):341-5. Epub 2006 May 19.

PMID:
16713702
18.

The Use of Minipigs for Preclinical Safety Assessment by the Pharmaceutical Industry: Results of an IQ DruSafe Minipig Survey.

Colleton C, Brewster D, Chester A, Clarke DO, Heining P, Olaharski A, Graziano M.

Toxicol Pathol. 2016 Apr;44(3):458-66. doi: 10.1177/0192623315617562.

PMID:
27006130
19.

Pharmaceuticals and medical devices: medical devices. Issue brief.

Berry MD.

Issue Brief Health Policy Track Serv. 2012 Dec 31:1-35. No abstract available.

PMID:
23297445

Supplemental Content

Support Center